Search

everythinglearnresearchcommunity

for

Search:↓

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Obese women with PCOS are more likely to have fatty liver disease.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Acquired Progressive Kinking of Hair is likely an early sign of male pattern baldness.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.